886498-03-9 Usage
Uses
Used in Pharmaceutical Industry:
2-FLUORO-5-(TRIFLUOROMETHOXY)PHENOL is used as a key intermediate in the synthesis of new drugs. Its unique structure and reactivity contribute to the development of innovative pharmaceutical compounds with improved therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2-FLUORO-5-(TRIFLUOROMETHOXY)PHENOL serves as a crucial building block for the creation of novel agrochemicals. Its incorporation into these products can enhance their effectiveness in agricultural applications.
Used in Materials Science:
2-FLUORO-5-(TRIFLUOROMETHOXY)PHENOL is utilized in materials science for the development of advanced materials. Its fluorinated nature provides specific properties that can be beneficial in various industrial applications, such as the creation of high-performance polymers and coatings.
Check Digit Verification of cas no
The CAS Registry Mumber 886498-03-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,4,9 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 886498-03:
(8*8)+(7*8)+(6*6)+(5*4)+(4*9)+(3*8)+(2*0)+(1*3)=239
239 % 10 = 9
So 886498-03-9 is a valid CAS Registry Number.
886498-03-9Relevant academic research and scientific papers
Discovery of chromane propionic acid analogues as selective agonists of GPR120 with in Vivo activity in rodents
Adams, Gregory L.,Velazquez, Francisco,Jayne, Charles,Shah, Unmesh,Miao, Shouwu,Ashley, Eric R.,Madeira, Maria,Akiyama, Taro E.,Salvo, Jerry Di,Suzuki, Takao,Wang, Nengxue,Truong, Quang,Gilbert, Eric,Zhou, Dan,Verras, Andreas,Kirkland, Melissa,Pachanski, Michele,Powles, Maryann,Yin, Wu,Ujjainwalla, Feroze,Venkatraman, Srikanth,Edmondson, Scott D.
supporting information, p. 96 - 101 (2017/12/13)
GPR120 (FFAR4) is a fatty acid sensing G protein coupled receptor (GPCR) that has been identified as a target for possible treatment of type 2 diabetes. A selective activator of GPR120 containing a chromane scaffold has been designed, synthesized, and eva
SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS GPR120 AGONISTS
-
Page/Page column 64, (2017/12/29)
The present invention relates to a compound represented by formula (I) and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, NASH, inflammation related disorders, and related di
